Shareholder Virtual Conference I
July 29th, 2020
We would like to thank the members of Harvard Medical School, National Institute of Health, our shareholders, advisors, partners and members for participating.
CoCaptain designs drugs to prevent Covid-19.
Our drug therapy prevents the disease.
This protocol can be taken to enhance vaccine actions.
Our hypothesis identifies Covid-19 as a disease affecting the primary resource of the immune system, Zinc. Through nanoparticle therapy we can overcome the effects of the virus.
We discuss our products, treatment, biochemistry of the virus and history of our Research and Development.
